Medicare, CVS Health
Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...
Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by ...
Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...
CVS Health is laying off nearly 3,000 "primarily corporate roles" in a cost-cutting move, the company confirmed to USA TODAY ...
Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.
CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.
Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical ...
CVS Health, one of the biggest players in the battle to acquire physicians, is facing a possible split amid major financial struggles. In 2023, CVS Health spent $10.6 billion to acquire primary care ...
Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health ...
Profitability pressures are expected to continue, driven by CVS Health's Insurance business. Read more to see why CVS stock ...
Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback